Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 921

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 8
Chunk 921
---
 Amortization 
      
     (251,260) 
     —  
     (8,296) 
     —  
     4,622  
     (254,934)
  
    Net Definite-Life Intangible Assets 
      
    $39,676  
    $—  
    $(8,296) 
    $—  
    $(1,337) 
    $30,043 

    Indefinite Life Intangible Assets and Goodwill 

    Goodwill 
      
     11,640,000  
     159,464,039  
     —  
     (11,640,000) 
     (133,878) 
     159,330,161 
  
    IPR&D 
      
     42,611,000  
     —  
     —  
     (42,611,000) 
     —  
     — 
  
    Total Indefinite Life Intangible Assets and Goodwill 
      
    $54,251,000  
    $159,464,039  
    $—  
    $(54,251,000) 
    $(133,878) 
    $159,330,161 

Expected future amortization expense is as follows:

    Schedule of future amortization expense 

    Years
    ended June 30, 

    2026 
    $36,350 
  
    2027 
     36,348 
  
    2028 
     32,348 
  
    2029 
     32,348 
  
    Thereafter 
     28,600 
  
    Total 
    $165,994 

    F-16

On February 13, 2024, the Company
acquired Renovaro Cube as a wholly owned subsidiary pursuant to a stock purchase agreement. As part of the acquisition of Renovaro
Cube, the Company acquired goodwill valued at $159,464,039.

On April 8, 2025, the Company
acquired Biosymetrics, Inc. as a wholly owned subsidiary pursuant to a stock purchase agreement. As part of the acquisition of Biosymetrics,
Inc., the Company acquired goodwill valued at $5,963,500, software valued at $143,000 and Trademark valued at $8,